abs410.txt	although	the	histone	methyltransferase	ezh2	and	its	product	h3k27me3	are	wellstudied	in	cancer		little	is	known	about	their	role	potential	as	therapeutictargets	endometriosis	we	have	previously	reported	that	endometriotic	lesionsare	characterized	by	global	enrichment	of	therefore	aimed	to	(1)characterize	expression	levels	tissues	(2)	assessh3k27me3	candidate	genes	promoter	regions	(3)	determine	ifpharmacological	inhibition	impacts	migration	proliferation	invasionof	cells	immunohistochemistry	an	endometriosis-focused	tissuemicroarray	was	used	assess	protein	chromatinimmunoprecipitation-qpcr	conducted	incandidate	gene	immunofluorescence	performed	toassess	effect	ezh2-specific	pharmacological	inhibitor	on	h3k27me3global	cell	lines	measure	effects	inmigration	invasion	vitro	scratch	brdu	andmatrigel	assays	respectively	lesions	had	significantly	higherezh2Î±	nuclear	immunostaining	compared	eutopic	endometrium	from	patients(glands	stroma)	controls	(glands)	enriched	within	promoterregions	some	but	not	all	reduced	cellsspecifically	also	ofendometriotic	epithelial	(12z)	these	findings	support	future	preclinicalstudies	vivo	efficacy	inhibitors	promising	nonhormonaltreatments	for	still	incurable	gynecological	disease
